EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST
- Written by PR Newswire Asia - News Pronto RSS
- INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%)
- The results of a comprehensive 483-sample case-control study established that INOVIQ's SubB2M/CA15-3 blood test significantly outperformed a leading approved CA15-3 test, demonstrating an area...
Read more: EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST